Physician profile
Robert B Dickinson
NPI 1306823463
$6,709.14
in general payments reported to CMS, 2019-2025
25 companies · $2,380 in 2025
The $2,380 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,508 · 2020: $147 · 2021: $72.23 · 2022: $535 · 2023: $1,078 · 2024: $989 · 2025: $2,380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,335 · Travel and Lodging: $1,107 · Education: $4.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,335.01 |
| Travel and Lodging | $1,107.22 |
| Education | $4.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,218.49 | 2022-2025 | Interstim, Altaviva |
| Neotract INC. | $1,323.91 | 2019-2020 | |
| Abbvie INC. | $540.66 | 2020-2025 | Botox |
| Sumitomo Pharma America, INC. | $277.89 | 2024-2025 | Gemtesa, Orgovyx |
| Axonics, INC. | $214.46 | 2022-2024 | Bulkamid, Axonics |
| Teleflex LLC | $141.46 | 2021-2024 | Urolift |
| Allergan, INC. | $129.32 | 2019-2022 | |
| Boston Scientific Corporation | $116.83 | 2022-2025 | Rezum Generator, Axonics |
| Procept Biorobotics Corporation | $106.83 | 2022-2025 | |
| Urogen Pharma, INC. | $95.02 | 2024-2025 | |
| Medtronic USA, INC. | $79.47 | 2019-2020 | |
| Accord Healthcare, INC. | $72.03 | 2024-2025 | |
| Astellas Pharma US INC | $68.56 | 2019-2025 | Xtandi |
| Endo Pharmaceuticals INC. | $59.94 | 2019-2023 | Aveed, Xiaflex, Edex |
| Janssen Biotech, INC. | $48.91 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $34.95 | 2024 | Cook |
| Ethicon US, LLC | $33.40 | 2025 | Echelon Circular |
| Olympus America INC. | $27.91 | 2025 | Itind System |
| Telix Pharmaceuticals | $21.57 | 2024 | Illuccix |
| Ferring Pharmaceuticals INC. | $19.94 | 2025 | Adstiladrin |
| Sun Pharmaceutical Industries INC. | $19.73 | 2025 | |
| Angiodynamics, INC. | $14.76 | 2025 | Nanoknife |
| Travere Therapeutics, INC. | $14.62 | 2020 | |
| Coloplast Corp | $14.49 | 2022 | |
| Antares Pharma, INC. | $13.99 | 2024 | Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dickinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.